Results 21 to 30 of about 175,158 (267)

Malignant Pleural Mesothelioma Treated in Clinic for Pulmonary Diseases and Tuberculosis “Podhrastovi“ in Ten-Year Period (from 1998 to 2007)

open access: yesBiomolecules & Biomedicine, 2008
Malignant pleural mesothelioma (MPM) is the most common primary malign tumour of pleura. The aim of this study was to evaluate cases of MPM diagnosed and treated in Clinic for Pulmonary Diseases and Tuberculosis “Podhrastovi” during ten-year period (1998-
Vesna Čukić   +5 more
doaj   +1 more source

THE DIAGNOSIS OF PULMONARY TUBERCULOSIS [PDF]

open access: yesBMJ, 1900
This may be a matter of considerable ease, or one of extreme difficulty, depending on the stage of the disease and the nature of the pathologic conditions. Let us first consider its diagnosis at an early stage. Tuberculosis is an infection, and as is the rule with infections, it occasions a rise of temperature even at its incipiency. Except very rarely,
openaire   +1 more source

"HETEROSEROTHERAPY" IN PULMONARY TUBERCULOSIS. [PDF]

open access: yesThe Lancet, 1919
n ...
Perkins, J. J.   +2 more
openaire   +2 more sources

PULMONARY TUBERCULOSIS

open access: yesThe American Journal of the Medical Sciences, 1923
Mode of access: Internet.
openaire   +1 more source

Lysine acetylation of DosR regulates the hypoxia response of Mycobacterium tuberculosis

open access: yesEmerging Microbes and Infections, 2018
Tuberculosis caused by Mycobacterium tuberculosis (Mtb) infection remains a large global public health problem. One striking characteristic of Mtb is its ability to adapt to hypoxia and trigger the ensuing transition to a dormant state for persistent ...
Hua Yang   +13 more
doaj   +1 more source

PCR-reverse blot hybridization assay in respiratory specimens for rapid detection and differentiation of mycobacteria in HIV-negative population

open access: yesBMC Infectious Diseases, 2021
Background Rapid identification of pathogenic Mycobacterium species is critical for a successful treatment. However, traditional method is time-consuming and cannot discriminate isolated non-tuberculosis mycobacteria (NTM) at species level.
Qing Zhang, Heping Xiao, Liping Yan
doaj   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Diagnostics for pulmonary tuberculosis [PDF]

open access: yesPostgraduate Medical Journal, 2016
AbstractTuberculosis (TB) remains a leading cause of human suffering and mortality despite decades of effective treatment being available. Accurate and timely diagnosis remains an unmet goal. The HIV epidemic has also led to new challenges in the diagnosis of TB.
Patrick Cudahy, Sheela V Shenoi
openaire   +2 more sources

Home - About - Disclaimer - Privacy